Skip to main content

Bellicum Pharmaceuticals Inc (NASDAQ: BLCM) Investor Securities Class Action Lawsuit 02/06/2018

  • If you purchased shares of Bellicum Pharmaceuticals Inc (NASDAQ: BLCM), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

May 29, 2020 - The court granted the defendants' motion to dismiss. July 5, 2019 - A motion to dismiss the amended complaint was filed. May 15, 2019 - An amended complaint was filed. February 6, 2018 - An investor in shares of Bellicum Pharmaceuticals Inc (NASDAQ: BLCM) filed a lawsuit in the U.S. District Court for the Southern District of Texas over alleged violations of Federal Sec...



You must register (for free) or login to view the entire case.